Human Genome Epidemiology Literature Finder
Records 1 - 10 (of 10 Records) |
Query Trace: Disease Progression and FGFR2[original query] |
---|
Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes. Breast cancer research and treatment 2012 Jun 133 (3): 843-51. Riaz Muhammad, Berns Els M J J, Sieuwerts Anieta M, Ruigrok-Ritstier Kirsten, de Weerd Vanja, Groenewoud Arwin, Uitterlinden Andrè G, Look Maxime P, Klijn Jan G M, Sleijfer Stefan, Foekens John A, Martens John W |
Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study. The Lancet. Oncology 2015 Jun 16 (6): 686-94. Konecny Gottfried E, Finkler Neil, Garcia Agustin A, Lorusso Domenica, Lee Paula S, Rocconi Rodney P, Fong Peter C, Squires Matt, Mishra Kaushal, Upalawanna Allison, Wang Yongyu, Kristeleit Rebec |
Frequency of EGFR T790M mutation and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tyrosine kinase inhibitors in Japanese patients. BMC cancer 2016 Nov 16 (1): 864. Ko Ryo, Kenmotsu Hirotsugu, Serizawa Masakuni, Koh Yasuhiro, Wakuda Kazushige, Ono Akira, Taira Tetsuhiko, Naito Tateaki, Murakami Haruyasu, Isaka Mitsuhiro, Endo Masahiro, Nakajima Takashi, Ohde Yasuhisa, Yamamoto Nobuyuki, Takahashi Kazuhisa, Takahashi Toshia |
Analysis of clinically relevant somatic mutations in high-risk head and neck cutaneous squamous cell carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2017 Oct . Zilberg Catherine, Lee Matthew Weicai, Yu Bing, Ashford Bruce, Kraitsek Spiridoula, Ranson Marie, Shannon Kerwin, Cowley Mark, Iyer N Gopalakrishna, Palme Carsten E, Ch'ng Sydney, Low Tsu-Hui Hubert, O'Toole Sandra, Clark Jonathan R, Gupta Ru |
Assessing inter-component heterogeneity of biphasic uterine carcinosarcomas. Gynecologic oncology 2018 9 151 (2): 243-249. Liu Yihua, Weber Zachary, San Lucas F Anthony, Deshpande Aditya, Jakubek Yasminka A, Sulaiman Raed, Fagerness Mary, Flier Natasha, Sulaiman Joseph, Davis Christel M, Fowler Jerry, Starks David, Rojas-Espaillat Luis, Lazar Alexander J, Davies Gareth E, Ehli Erik A, Scheet Pa |
Limited Practical Utility of Liquid Biopsy in the Treated Patients with Advanced Breast Cancer. Diagnostics (Basel, Switzerland) 2020 Jul 10 (8): . Niwinska Anna, Ba?abas Aneta, Kulecka Maria, Kluska Anna, Pi?tkowska Magdalena, Paziewska Agnieszka, Py?niak Kazimiera, Olszewski Wojciech, Mikula Micha?, Ostrowski Jer |
NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment. Molecular oncology 2021 May . Sánchez-Herrero Estela, Serna-Blasco Roberto, Ivanchuk Vadym, García-Campelo Rosario, Dómine Gómez Manuel, Sánchez José M, Massutí Bartomeu, Reguart Noemi, Camps Carlos, Sanz-Moreno Sandra, Calabuig-Fariñas Silvia, Jantus-Lewintre Eloísa, Arnal Magdalena, Fernández-Orth Dietmar, Calvo Virginia, González-Rumayor Víctor, Provencio Mariano, Romero Atoc |
Exceptional Response to Erdafitinib in FGFR2-Mutated Metastatic Pancreatic Ductal Adenocarcinoma. Journal of the National Comprehensive Cancer Network : JNCCN 2022 10 20 (10): 1076-1079. Ng Camille F, Glaspy John, Placencio-Hickok Veronica R, Thomassian Shant, Gong Jun, Osipov Arsen, Hendifar Andrew E, Moshayedi Natal |
The Significance of Human Papillomavirus Receptors Related Genetic Variants in Cervical Cancer Screening. Microbiology spectrum 2023 6 e0511722. Hongyu Xie, Mingjing Wei, Lifang Yao, Yi Liu, Xing Xie, Xiao |
FGFR2 point mutation in 2 cases of pleomorphic adenoma progressing to myoepithelial carcinoma. Contemporary oncology (Poznan, Poland) 2024 1 27 (3): 211-216. Julia Pikul, Anna Rzepakowska, Marcin Machnicki, Tomasz Stok?o |
- Page last reviewed:Feb 1, 2024
- Content source: